Single-use Bioprocessing Market Size To Hit USD 74.09 Billion By 2030

 San Francisco, 11 December 2025: The Report Single-use Bioprocessing Market (2025 - 2030) Size, Share & Trends Analysis Report By Product (Simple & Peripheral Elements, Apparatus & Plants), By Workflow (Upstream, Downstream), By End Use, By Region, And Segment Forecasts

The global single-use bioprocessing market size is projected to reach USD 74.09 billion by 2030, registering a CAGR of 15.44% from 2025 to 2030, according to a new report by Grand View Research, Inc. The demand for single-use bioprocessing offerings is driven by the commercial advantages offered, including a reduction in costs and time required for bioprocessing operations. Originally used for monoclonal antibody production, single-use technologies are also gaining traction for cell and gene therapy manufacturing. As a result, broadening the scope of applications in biomanufacturing operations is likely to drive industry growth.

Furthermore, strategic initiatives from key players are expanding the industry's growth prospects. For instance, in July 2021, Cytiva and Pall Corp. announced investment plans for capacity expansion over two years. Among other key products, more than USD 300 million were invested in single-use technologies, such as bioreactor bags for cell expansion, used to make personalized therapies and syringe filters for scientific research. Similarly, the growing adoption of single-use equipment for in-house and contract manufacturing has opened new avenues for the flow of investments in this space. The industry is witnessing significant advancements in several product portfolios, including disposable probes and sensors, stirring systems, bioreactor designs, and filtration technologies, which are expected to contribute to strong revenue growth.

The benefits offered by single-use bioprocessing systems have enabled biopharmaceutical manufacturers to offer their products faster to the market by introducing multi-product facilities, entering into partnerships, or outsourcing pipeline products for contract development and manufacturing. For instance, in January 2021, Sartorius AG partnered with RoosterBio, a leading supplier of human Mesenchymal Stem/Stromal Cells (hMSC). This collaboration aimed at advancing cell & gene therapy manufacturing by leveraging the single-use manufacturing technologies from Sartorius AG. The COVID-19 pandemic has generated new growth opportunities for key stakeholders in the industry.

Key biopharmaceutical players can leverage the opportunity by expanding their COVID-19-related product offerings by scaling up their production facilities with the implementation of single-use bioprocessing equipment. A significant number of biopharmaceutical companies are actively involved in the development and production of COVID-19 vaccines. These programs are majorly based on single-use technologies as these systems are flexible, cost-effective, and reduce the risk of cross-contamination. Such an ongoing and continuous increase in the adoption of bioprocessing systems due to the COVID-19 pandemic is anticipated to drive industry growth.

Access Research Report of Single-use Bioprocessing Market @ https://www.grandviewresearch.com/industry-analysis/single-use-bioprocessing-market

Single-use Bioprocessing Market Report Highlights

• The simple & peripheral elements segment recorded the largest market share of 48.82% in 2024 due to continuous innovations in these products and increasing prominence of bioprocessing operations in overall manufacturing process.
• Upstream bioprocessing segment held the largest market share of 58.23% in 2024 and expected to register fastest CAGR over the forecast period.
• The biopharmaceutical manufacturers dominated the market and accounted for the largest share 2024.
• North America held the largest revenue share of more than 34.96% in 2024, which can be attributed to the presence of an established pharmaceutical and biomanufacturing industry in the region as well as a high extent of R&D activities.

Grand View Research has segmented the global single-use bioprocessing market on the basis of product, workflow, end use, and region:

Single-use Bioprocessing Product Outlook (Revenue, USD Million, 2018 - 2030)

• Simple & Peripheral Elements
  • Tubing, Filters, Connectors, & Transfer Systems
  • Bags
  • Sampling Systems
  • Probes & Sensors
    • pH Sensor
    • Oxygen Sensor
    • Pressure Sensors
    • Temperature Sensors
    • Conductivity Sensors
    • Flow Sensors
    • Others
  • Others
• Apparatus & Plants
  • Bioreactors
    • Upto 1000L
    • Above 1000L to 2000L
    • Above 2000L
  • Mixing, Storage, & Filling Systems
  • Filtration System
  • Chromatography Systems
  • Pumps
  • Others
• Work Equipment
  • Cell Culture System
  • Syringes
  • Others

Single-use Bioprocessing Workflow Outlook (Revenue, USD Million, 2018 - 2030)

• Upstream Bioprocessing
• Fermentation
• Downstream Bioprocessing

Single-use Bioprocessing End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Biopharmaceutical Manufacturers
  • CMOs & CROs
  • In-house Manufacturers
• Academic & Clinical Research Institutes

Single-use Bioprocessing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)

List of key players in Single-use Bioprocessing Market

• Sartorius AG
• Danaher Corporation
• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Avantor, Inc.
• Eppendorf SE
• Corning Incorporated
• Boehringer Ingelheim International GmbH
• Lonza
• Infors AG

Access Press Release of Single-use Bioprocessing Market @ https://www.grandviewresearch.com/press-release/global-single-use-bioprocessing-market

About Grand View Research

Grand View Research is an India & U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services.

For More Information: https://www.grandviewresearch.com/horizon